Ascendis Pharma AS Cash Flow Quality Index

Latest as of March 2026: -0.01x

Ascendis Pharma AS cash flow quality index. Ascendis Pharma AS (ASND) has a Cash Flow Quality Index of -0.01x as of March 2026. Operating cash flow of $-7.85 Million is below net income of $639.69 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Ascendis Pharma AS (ASND) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.01x
Operating CF / Net Income

Operating Cash Flow

$-7.85 Million
USD

Net Income

$639.69 Million
USD

Data as of

Mar 2026
Most recent filing

Cash Flow Quality Index of Ascendis Pharma AS (2012–2013)

Cash flow quality index of Ascendis Pharma AS from 2012 to 2013. Historical Cash Flow Quality Index for Ascendis Pharma AS across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. See ASND equity financing ratio to measure how much of total assets are equity-financed.

Ascendis Pharma AS Cash Flow Quality Index by Year (2012–2013)

Ascendis Pharma AS cash flow quality index by year from 2012 to 2013. Year-by-year earnings quality comparison for Ascendis Pharma AS. For the full cash flow conversion analysis, see Ascendis Pharma AS operating cash flow efficiency.

Year Quality Index Operating CF (USD) Net Income YoY Change
2013 1.55x $6.31 Million $4.08 Million ▲ +396.6%
2012 -0.52x $-652.00K $1.25 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.